ARBE vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

ARBE

40.5
AI Score
VS
ARBE Wins

MLAB

33.7
AI Score

Investment Advisor Scores

ARBE

41score
Recommendation
HOLD

MLAB

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ARBE MLAB Winner
Revenue 458,000 60.14M MLAB
Net Income -10.16M 2.83M MLAB
Gross Margin -16.6% 64.9% MLAB
Net Margin -2218.6% 4.7% MLAB
Operating Income -11.58M 7.03M MLAB
ROE -25.7% 1.5% MLAB
ROA -13.8% 0.7% MLAB
Total Assets 73.85M 419.22M MLAB
Cash 4.03M 30.70M MLAB
Current Ratio 2.18 1.79 ARBE
Free Cash Flow -9.04M 14.18M MLAB

Relative Price Performance (Last 90 Days)

ARBE 1M: +0.6% · 3M: -39.9% MLAB 1M: +23.6% · 3M: +14.3%

Current Technical Phase

ARBE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.2 · Price: $0.72

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 72

RSI (14): 71.7 · Price: $124.76

Fundamentals Snapshot

Metric ARBE MLAB
Market Cap
Forward P/E -4.8 23.2
Trailing P/E 140.2
Revenue (TTM)
Revenue Growth 1.6% 0.0%
Gross Margin -0.2% 0.6%
Operating Margin -14.0% 0.1%
EPS -0.34 0.85
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, ARBE is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.